Increasing evidence suggests a role of neuroinflammation in substance use disorders (SUDs). This Review presents findings from neuroimaging studies assessing brain markers of inflammation in vivo in individuals with SUDs. Most studies investigated the translocator protein 18 kDa (TSPO) using PET; neuroimmune markers myo-inositol, choline-containing compounds, and N-acetyl aspartate using magnetic resonance spectroscopy; and fractional anisotropy using MRI. Study findings have contributed to a greater understanding of neuroimmune function in the pathophysiology of SUDs, including its temporal dynamics (i.e., acute versus chronic substance use) and new targets for SUD treatment.
Xinyi Li, Astrid P. Ramos-Rolón, Gabriel Kass, Lais S. Pereira-Rufino, Naomi Shifman, Zhenhao Shi, Nora D. Volkow, Corinde E. Wiers
Title and authors | Publication | Year |
---|---|---|
Ginsenoside Rg1 alleviates chronic stress-induced depression in rats by targeting Cx43-YAP axis.
Wang HQ, Zheng RF, Ai QD, Yang SW, Yang XY, Chen AP, Yan Q, Yan X, Zhang Z, Xing JG, Chu SF, Wang ZZ, Yang YT, Chen NH |
Acta pharmacologica Sinica | 2025 |
Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome
Laura M Bartos, Stefanie Quach, Valerio Zenatti, Sabrina V Kirchleitner, Jens Blobner, Karin Wind-Mark, Zeynep Ilgin Kolabas, Selin Ulukaya, Adrien Holzgreve, Viktoria C Ruf, Lea H Kunze, Sebastian T Kunte, Leonie Hoermann, Marlies Härtel, Ha Eun Park, Mattes Gross, Nicolai Franzmeier, Artem Zatcepin, Adrian Zounek, Lena Kaiser, Markus Riemenschneider, Robert Perneczky, Boris-Stephan Rauchmann, Sophia Stoecklein, Sibylle Ziegler, Jochen Herms, Ali Ertuerk, Joerg C Tonn, Niklas Thon, Louisa von Baumgarten, Matthias Prestel, Sabina Tahirovic, Nathalie L Albert, Matthias Brendel |
Clinical cancer research | 2024 |
Therapeutic targeting of neuroinflammation in methamphetamine use disorder
Jeffery N, Mock PY, Yang K, Tham CL, Israf DA, Li H, Wang X, Lam KW |
Future Medicinal Chemistry | 2024 |